InDex Pharmaceuticals Holding AB (publ)

OM:INDEX Stok Raporu

Piyasa değeri: SEK 286.6m

This company is no longer active

The company may no longer be operating, as it may be out of business. Find out why through their latest events.

InDex Pharmaceuticals Holding Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

InDex Pharmaceuticals Holding has a total shareholder equity of SEK236.0M and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK280.9M and SEK44.9M respectively.

Anahtar bilgiler

0%

Borç/özkaynak oranı

SEK 0

Borç

Faiz karşılama oranın/a
NakitSEK 269.82m
EşitlikSEK 235.98m
Toplam yükümlülüklerSEK 44.92m
Toplam varlıklarSEK 280.90m

Son finansal sağlık güncellemeleri

Recent updates

Market Might Still Lack Some Conviction On InDex Pharmaceuticals Holding AB (publ) (STO:INDEX) Even After 35% Share Price Boost

Jun 13
Market Might Still Lack Some Conviction On InDex Pharmaceuticals Holding AB (publ) (STO:INDEX) Even After 35% Share Price Boost

Further Upside For InDex Pharmaceuticals Holding AB (publ) (STO:INDEX) Shares Could Introduce Price Risks After 26% Bounce

Apr 28
Further Upside For InDex Pharmaceuticals Holding AB (publ) (STO:INDEX) Shares Could Introduce Price Risks After 26% Bounce

We're Keeping An Eye On InDex Pharmaceuticals Holding's (STO:INDEX) Cash Burn Rate

Jul 11
We're Keeping An Eye On InDex Pharmaceuticals Holding's (STO:INDEX) Cash Burn Rate

We Think InDex Pharmaceuticals Holding (STO:INDEX) Can Afford To Drive Business Growth

Jan 21
We Think InDex Pharmaceuticals Holding (STO:INDEX) Can Afford To Drive Business Growth

We Think InDex Pharmaceuticals Holding (STO:INDEX) Can Afford To Drive Business Growth

Aug 31
We Think InDex Pharmaceuticals Holding (STO:INDEX) Can Afford To Drive Business Growth

Here's Why We're Watching InDex Pharmaceuticals Holding's (STO:INDEX) Cash Burn Situation

Mar 29
Here's Why We're Watching InDex Pharmaceuticals Holding's (STO:INDEX) Cash Burn Situation

InDex Pharmaceuticals Holding's (STO:INDEX) Shareholders Are Down 24% On Their Investment Over The Past Year.

Feb 04
InDex Pharmaceuticals Holding's (STO:INDEX) Shareholders Are Down 24% On Their Investment Over The Past Year.

How Much Are InDex Pharmaceuticals Holding AB (publ) (STO:INDEX) Insiders Spending On Buying Shares?

Dec 21
How Much Are InDex Pharmaceuticals Holding AB (publ) (STO:INDEX) Insiders Spending On Buying Shares?

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: INDEX's short term assets (SEK278.4M) exceed its short term liabilities (SEK43.6M).

Uzun Vadeli Yükümlülükler: INDEX's short term assets (SEK278.4M) exceed its long term liabilities (SEK1.3M).


Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: INDEX is debt free.

Borcun Azaltılması: INDEX has not had any debt for past 5 years.


Bilanço


Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: INDEX has sufficient cash runway for more than 3 years based on its current free cash flow.

Tahmini Nakit Akışı: INDEX has sufficient cash runway for more than 3 years if free cash flow continues to grow at historical rates of 0.2% each year


Sağlıklı şirketleri keşfedin